NANT 2011- 01: Randomized Phase II Pick the Winner Study of 131I-MIBG, 131I-MIBG With Vincristine and Irinotecan, or 131I-MIBG With Vorinostat for Resistant/Relapsed Neuroblastoma

Trial Profile

NANT 2011- 01: Randomized Phase II Pick the Winner Study of 131I-MIBG, 131I-MIBG With Vincristine and Irinotecan, or 131I-MIBG With Vorinostat for Resistant/Relapsed Neuroblastoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Iobenguane (Primary) ; Irinotecan; Vincristine; Vorinostat
  • Indications Neuroblastoma
  • Focus Therapeutic Use
  • Acronyms NANT2011-01
  • Most Recent Events

    • 11 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.
    • 11 Aug 2017 Status changed from active, no longer recruiting to recruiting.
    • 21 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top